SCHEMBL25663145

SCHEMBL25663145

c1cnc2ccc(-c3ccc(N(c4ccc(-c5ccc6ncccc6c5)cc4)c4ccc5cc(-c6ncnc7c6sc6ncccc67)ccc5c4)cc3)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 6/20 0.42
▸ LIMK1 P53667 2/20 0.42
▸ CDC7 O00311 1/20 0.42
▸ DBF4 Q9UBU7 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PIK3CA P42336 4/20 0.39
▸ EGFR P00533 3/20 0.37
▸ DYRK1A Q13627 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ SRC P12931 4/20 0.35
▸ PIK3CD O00329 3/20 0.35
▸ PIK3CB P42338 3/20 0.35
▸ MTOR P42345 3/20 0.35
▸ PIK3CG P48736 3/20 0.35
▸ ABL1 P00519 2/20 0.35
▸ HCK P08631 2/20 0.35
▸ KDR P35968 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663147 0.92 PIK3CA (0.41) CLK1LIMK1CDC7DBF4PIK3CA
SCHEMBL25663137 0.90 CLK1 (0.45) CLK1LIMK1CDC7DBF4NPC1
SCHEMBL25663140 0.89 CLK1 (0.44) CLK1LIMK1CDC7DBF4PIK3CA
SCHEMBL25663143 0.88 CLK1 (0.40) CLK1LIMK1CDC7DBF4NPC1
SCHEMBL25663136 0.86 CLK1 (0.44) CLK1LIMK1CDC7DBF4PIK3CA
SCHEMBL25663126 0.86 CLK1 (0.45) CLK1LIMK1CDC7DBF4NPC1
SCHEMBL25663146 0.86 CLK1 (0.40) CLK1LIMK1CDC7DBF4NPC1
SCHEMBL25663148 0.85 LIMK1 (0.38) LIMK1NPC1POLBRAB9APIK3CA
SCHEMBL25663127 0.84 CLK1 (0.44) CLK1LIMK1CDC7DBF4PIK3CA
SCHEMBL25663139 0.82 CLK1 (0.42) CLK1LIMK1CDC7DBF4PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 CLK1 1567/4885LIMK1 1044/4885CDC7 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback